Literature DB >> 23149802

Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.

Barbara Deconinck1, Johny Verschakelen, Johan Coolen, Eric Verbeken, Geert Verleden, Wim Wuyts.   

Abstract

PURPOSE: The term diffuse parenchymal lung disease (DPLD) refers to a group of disorders affecting the lung parenchyma that can be categorized into those of known and those of unknown etiology. Early diagnosis is important since some forms of DPLD are characterized by a rapid progression to respiratory failure. Notwithstanding the fact that recently guidelines have been published, some issues concerning the practical evaluation of a patient with suspected DPLD remain unclear.
METHODS: In this article we propose a practical approach to the diagnosis and differentiation of DPLD. Moreover, a critical appraisal is provided based on the current literature and frequent pitfalls are highlighted.
CONCLUSION: we propose a practical workup, but in spite of increasing evidence concerning the diagnosis of DPLD, further studies will be needed to clarify several issues for efficient investigation of newly diagnosed patients with DPLD.

Entities:  

Mesh:

Year:  2012        PMID: 23149802     DOI: 10.1007/s00408-012-9433-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  47 in total

1.  Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.

Authors:  Shinichiro Ohshimo; Francesco Bonella; Ai Cui; Martin Beume; Nobuoki Kohno; Josune Guzman; Ulrich Costabel
Journal:  Am J Respir Crit Care Med       Date:  2009-02-26       Impact factor: 21.405

2.  Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.

Authors:  Sonali K Sanghavi; Kareem Abu-Elmagd; Maria Cristina Keightley; Kirsten St George; Kathleen Lewandowski; Stephanie S Boes; Arlene Bullotta; Ryan Dare; Maryann Lassak; Shahid Husain; Eun J Kwak; David L Paterson; Charles R Rinaldo
Journal:  J Clin Virol       Date:  2008-05-21       Impact factor: 3.168

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  Autoimmune-featured interstitial lung disease: a distinct entity.

Authors:  Rekha Vij; Imre Noth; Mary E Strek
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

5.  Connective tissue disease-associated interstitial lung disease: a call for clarification.

Authors:  Aryeh Fischer; Sterling G West; Jeffrey J Swigris; Kevin K Brown; Roland M du Bois
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

6.  A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients.

Authors:  Tomoko Nozu; Mitsuko Kondo; Kazuo Suzuki; Jun Tamaoki; Atsushi Nagai
Journal:  Respiration       Date:  2008-12-11       Impact factor: 3.580

7.  Clinical diagnosis of hypersensitivity pneumonitis.

Authors:  Yves Lacasse; Moises Selman; Ulrich Costabel; Jean-Charles Dalphin; Masayuki Ando; Ferran Morell; Riitta Erkinjuntti-Pekkanen; Nestor Muller; Thomas V Colby; Mark Schuyler; Yvon Cormier
Journal:  Am J Respir Crit Care Med       Date:  2003-07-03       Impact factor: 21.405

Review 8.  Pulmonary function testing in interstitial lung diseases.

Authors:  Alfredo Chetta; Emilio Marangio; Dario Olivieri
Journal:  Respiration       Date:  2004 May-Jun       Impact factor: 3.580

9.  Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens.

Authors:  Pierre Flori; Bahrie Bellete; Fabrice Durand; Hélène Raberin; Céline Cazorla; Jamal Hafid; Frédéric Lucht; Roger Tran Manh Sung
Journal:  J Med Microbiol       Date:  2004-07       Impact factor: 2.472

10.  BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Jürgen Behr; Kevin K Brown; Roland M du Bois; Lisa Lancaster; Joao A de Andrade; Gerd Stähler; Isabelle Leconte; Sébastien Roux; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

View more
  3 in total

1.  [Therapeutic relevance of HRCT findings from a pneumological viewpoint].

Authors:  R Suchy; M Pfeifer
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

2.  A Single US Center Experience of Transbronchial Lung Cryobiopsy for Diagnosing Interstitial Lung Disease With a 2-Scope Technique.

Authors:  Thitiwat Sriprasart; Alejandro Aragaki; Robert Baughman; Kathryn Wikenheiser-Brokamp; Gaurav Khanna; Daniel Tanase; Michelle Kirschner; Sadia Benzaquen
Journal:  J Bronchology Interv Pulmonol       Date:  2017-04

Review 3.  State of the art in the diagnosis and management of interstitial lung disease.

Authors:  Maria T A Buzan; Carmen Monica Pop
Journal:  Clujul Med       Date:  2015-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.